Correlation of HLA-A and HLA-B/C Expression With PD-1 and PD-L1 Expression in Patients With Metastatic Breast Cancer as a Potential Prognosticator of Favorable Survival
This pilot study found no significant association between HLA-A, HLA-B/C, PD-1, or PD-L1 expression and OS in MBC, indicating limited prognostic value for these biomarkers in this cohort.
Authors
- Jan Hofmann (ORCID: https://orcid.org/0000-0001-9572-8528)
- Uroš Karić (ORCID: https://orcid.org/0000-0003-2154-7315)
- Markus Wallwiener (ORCID: https://orcid.org/0000-0002-4139-9340)
- Aleksandra Djurić-Stefanović (ORCID: https://orcid.org/0000-0002-5796-835X)
- MAXIMILIAN KOHLER
- Thomas Maximilian Deutsch (ORCID: https://orcid.org/0000-0003-0621-1290)
- Ralph M. Wirtz (ORCID: https://orcid.org/0000-0001-9054-8579)
- Marc Sütterlin (ORCID: https://orcid.org/0000-0003-0205-2552)
- Andreas Schneeweiß (ORCID: https://orcid.org/0000-0002-2429-4512)
- Lukas Goerdt
- Stefan Stefanović (ORCID: https://orcid.org/0000-0002-1347-2133)
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- National Center for Tumor Diseases (DE)
- Diakonissenkrankenhaus (DE)
- Martin Luther University Halle-Wittenberg (DE)
Publication Details
- Journal
- In Vivo
- Published
- 2025-02-26
- DOI
- https://doi.org/10.21873/invivo.13880
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05